produced approximately 50 million paired reads per sample, more than 97% of which were mapped to the genome. The average coverage was 52×, with more than 80% of targeted bases covered at 20×. Reads were mapped to the human reference genome sequence (assembly GRCh37/hg19), and allelic variants were detected. About 60,000 variants were called per individual (Supplementary Table 2 ). Because dystonia is rare and inherited in an autosomal dominant manner in these pedigrees, the causative mutation is expected to be an extremely rare heterozygous variant shared by all affected family members. Comparing sequenced family members, we found 11,124 heterozygous shared variants in family P and 4,578 in family D1. These variants were further compared to dbSNP release 132, with 458 and 208 previously unknown variants identified in each family, respectively. After annotation by both the SIFT 16 and SeattleSeq Annotation servers, 68 missense and 1 nonsense variants remained in family P, and 20 missense variants were defined in family D1 (Supplementary Table 2 ). Identification of insertion and/or deletion (indel) variants was performed in a similar fashion for family P only (Online Methods and Supplementary Table 3) .
Family P was previously subjected to a whole-genome scan that identified 3 regions of potential linkage, with logarithm of odds (LOD) scores ranging from 1.5 to 2.1 (data not shown). Within these regions, we found seven new coding variants: four single-nucleotide substitutions and three indels that were shared by all three affected individuals in family P.
Among these variants, the mutation encoding a p.Ser293* alteration in the GNAL gene cosegregated with dystonia in the remaining members of family P (Supplementary Fig. 1) . Furthermore, an additional variant in this gene, encoding a p.Val137Met alteration, was found among the 20 missense variants shared by all 4 members in family D1; it segregated with the disease in this family (Supplementary Fig. 1 ) and was not observed in the 572 control chromosomes we tested. In addition, neither the p.Ser293* nor p.Val137Met alteration was l e t t e r s found in ~3,500 European exomes in the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project database.
To confirm GNAL as a causative gene for dystonia, we performed Sanger sequencing of its entire coding region in 39 additional families with multiplex PTD of mixed European origin who were negative for mutations in TOR1A and THAP1. We detected new mutations in the GNAL gene in six additional families (19%), including one nonsense mutation (encoding p.Arg21*), two frameshift mutations (encoding p.Ser95fs*110 and p.Arg198fs*210), one missense mutation (encoding p.Glu155Lys), one in-frame deletion of three amino acids (p.Pro102_Val104del) and one possible splice-site mutation at chromosome 18: 11,753,820 (hg19) (c.274-5T>C) upstream of exon 4 of GNAL (Fig. 1a, Table 1 and Supplementary Fig. 1 ). Bioinformatics analysis enumerating all possible splice sites in the human genome suggests that the wild-type sequence is ten times more likely to be found near an acceptor splice site than the mutant sequence 17 . However, we were unable to prove this hypothesis in samples from affected individuals, as lymphoblasts were the only tissue available, and GNAL expression is undetectable by semiquantitative PCR and protein blot analysis in these cells (data not shown). None of the variants were detected in dbSNP135, ~3,500 European exomes or the 572 control chromosomes that we tested. Segregation analyses confirmed transmission of the GNAL mutations with the disease phenotype in all families for which DNA from multiple affected individuals was available (Supplementary Fig. 1 ). The Val137 and Glu155 codons were completely conserved in GNAL orthologs (Fig. 1b) . In addition to the coding variants in individuals with dystonia, we found one new synonymous variant, encoding p.Glu18Glu, and one new nonsynonymous substitution, encoding p.Val16Phe, each in a single control subject and not in any database.
Among the 8 families with mutations, there were 28 individuals with complete clinical information who had definite dystonia ( Table 1  and Supplementary Table 1 ). The average age of dystonia onset in the mutation carriers was 31.3 years and ranged from 7-54 years. Most carriers (82%) had onset in the neck, and 93% had neck involvement at final exam; however, most progressed to have dystonia at other sites, and only 46% had focal dystonia at last exam. Further, cranial involvement was present in 57% of carriers, and 44% had npg l e t t e r s speech involvement. Brachial onset was not observed, and eventual arm involvement was seen in only 32% of carriers, distinguishing the phenotypic consequences of GNAL mutations from those of THAP1 mutation (Supplementary Table 4 ) 14, 18 . All carriers were Caucasian of mixed European ancestry. Because it has been suggested that GNAL may be imprinted 19 , we examined the parental origin of the mutations. Dystonia was inherited from the maternal and paternal sides equally, and there were no apparent phenotypic differences between maternally and paternally inherited cases. However, further study is required to fully determine whether the parental origin of the mutation affects penetrance or expression. In addition, no genotypephenotype correlation could be discerned with regard to mutation type, and phenotypes varied within families with the same mutation ( Table 1 and Supplementary Table 1) . GNAL is located on chromosome 18p centromeric to the DYT7 locus for focal dystonia 20 and the DYT15 locus for myoclonus dystonia 21, 22 . Dystonia occurs in individuals with 18p deletion [23] [24] [25] [26] [27] [28] , and the absence of GNAL may contribute to dystonia in these cases. GNAL encodes the stimulatory α subunit, Gα olf , first identified as a G protein (guanine nucleotide-binding protein) that mediates odorant signaling in the olfactory epithelium 29 . G proteins link seven-transmembrane-domain receptors to downstream effector molecules and function as heterotrimers composed of α, β and γ subunits 30 . The predominant stimulatory G protein subunit in the brain is Gα s , but Gα olf replaces Gα s in striatal medium spiny neurons (MSNs) 31, 32 . In MSNs, Gα olf couples dopamine type 1 receptors (D1Rs) of the direct pathway and adenosine A2A receptors (A2ARs) of the indirect pathway to the activation of adenylate cyclase type 5 (refs. [33] [34] [35] Figure 1 Mutations identified in GNAL in individuals with PTD. (a) Schematic of the exonintron structure of the short isoform of GNAL (NM_001142339) with mutations indicated. Missense mutations are shown in purple, the in-frame deletion is shown in blue, nonsense mutations are shown in green, frameshift mutations are shown in yellow, and the tentative splice-site mutation is shown in gray. (b) Protein sequence alignment of Gα olf in vertebrate species. Protein sequences were obtained from the RefSeq database and aligned using ClustalW 57 . The regions of alignment corresponding to the in-frame deletion and missense mutations are shown. Altered residues are colored as in a. RefSeq accession numbers are given. Gα olf and Gβγ (detected by antibody to green fluorescent protein (GFP)) subunits by protein blotting. Ponceau S staining of total cell lysates was used as a loading control. Results represent the mean of quadruplicate wells from a typical experiment. Similar results were seen in two independent experiments. Error bars, s.e.m. One-way ANOVA followed by the Holm-Sidak method was performed to determine statistically significant differences relative to wild-type control: ***P < 0.001. The vectors expressing Gα olf were designed using the transcript NM_001142339. 
-of-function phenotype. In addition, the Arg21* variant is likely degraded by nonsense-mediated decay, thus producing no protein.
To investigate the impact of small deletions and more subtle missense mutations (Fig. 2) , we used a cell-based BRET reporter system in which Gα olf function is assessed by its ability to interact with Gβγ subunits during the receptor-initiated cycle of nucleotide binding and hydrolysis. Introduction of wild-type Gα olf resulted in significantly less Gβγ interaction with the effector-based reporter, indicating efficient formation of the Gα olf -Gβγ heterotrimer. Stimulation of D1R with dopamine resulted in a rapid increase in the BRET signal, reflecting Gα olf activation and resultant release of the Gβγ subunits. Conversely, inactivation of D1R rapidly brought the signal to baseline, owing to GTP hydrolysis and heterotrimer reassociation. The Ser293* deletion mutant did not support any D1R-driven responses, whereas Val16Phe, a variant found in a single control sample, showed normal wild type-like behavior. Two mutants found in individuals with dystonia, Glu155Lys and Val137Met, showed intermediate pheno types largely consistent with impaired association with the Gβγ subunits (Fig. 2) .
Although dysfunction of the basal ganglia is not the exclusive etiology of dystonia, abundant evidence supports the involvement of its many circuits, including dopamine pathways [38] [39] [40] [41] [42] . Further, in the basal ganglia, an imbalance between the indirect (dopamine type 2 receptor, D2R) and direct (D1R) pathways has been hypothesized, initiated by primary abnormalities in either the D2R 42 or cholinergic 43 systems. The identification of causative mutations in GNAL points to primary abnormalities in D1R and/or A2AR transmission as possibly leading to dystonia.
The amount of Gα olf is rate limiting in the activation of adenylate cyclase type 5 after D1R stimulation 36, 44 . Heterozygote Gnal-null mice show a muted response to acute psychostimulant and caffeine exposure 44 . Homozygote null mice are anosmic and hyperactive at baseline and do not respond to acute psychostimulant exposure, but they do not manifest an overt movement disorder [44] [45] [46] . As a rate-limiting mediator of the D1R signal transduction system, Gα olf has been physiologically linked to levodopa-induced dyskinesias (LID) 47, 48 , a debilitating disorder arising from chronic administration of l-DOPA in individuals with Parkinson's disease (reviewed in ref. 49) . We have previously posited the existence of compensatory alterations in the D1R signal transduction system in transgenic mice overexpressing mutant torsinA in dopaminergic neurons and suggested a shared molecular abnormality in dystonia and LID on the basis of the dopamine release deficit in mice encoding a Dyt1 mutation 41, 50 . Within the striatum, Gα olf is enriched in the striosomal compartment 51 , and it has been hypothesized that an imbalance in striosomal activity relative to the matrix compartment is an etiological factor in the development of hyperkinetic movement disorders 52 . Genetically, Gα olf has been associated with hyperactivity in attention deficit hyperactivity disorder and schizophrenia, although mutations have not been identified in individuals with these disorders [53] [54] [55] .
In conclusion, we have identified eight different mutations in GNAL, a new causative gene in primary dystonia. The phenotype in the eight multiplex families is predominantly one of cervical dystonia, with a relatively broad range in the age of onset and spread to other muscles, especially the facial muscles, in over one-half of subjects. Refinement of this phenotype, as well as the role of GNAL in sporadic PTD, awaits further screening in both familial and sporadic cohorts. A functional assay testing several of the mutations is suggestive of loss of function. Along with mutations in the tyrosine hydroxylase biosynthetic pathway in dopamine-responsive dystonia (DRD) 56 , the identification of mutations in GNAL directly points to abnormalities in the dopamine and/or adenosine signal transduction pathways as the origin of dystonia pathophysiology. However, unlike the mutations in DRD, GNAL mutations place the primary causative abnormality postsynaptically in striatal dopaminoceptive neurons and/or cholinergic interneurons.
URLs. SeattleSeq Annotation, http://snp.gs.washington.edu/ SeattleSeqAnnotation/; NHLBI Exome Variant Server, http://evs. gs.washington.edu/EVS/.
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